...is the most advanced means of documenting eye dise...nt system that acquires extremely high quality col...es can be captured directly from slit lamps equipp...ther ophthalmic device with video or TWAIN output....
Two mirrored surfaces, which each incline at an angle of 62 towards the front surface, have been cut into the 17 mm long glass cone. This makes it possible to examine the opposite iridocorneal angle
The best combination with the Haag-Streit 900 Slitlamps. For examination of the entire fundus, the vitreous and the iridocorneal angle. The classic Goldmann Glass.
Orthofix's retrograde nail provides easier insertion of nail by rotational movements.
Medicine Products:(Date:7/25/2008)...wswire/ -- Sagent Pharmaceuticals, Inc.,a private...nounced that it,has launched amiodarone HCl inject... the treatment and prophylaxis of frequently recur...unstable ventricular,tachycardia -- a potentially ...iodarone HCl injection will be available immediate...
(Date:7/25/2008)...gus can cause immune system changes , , ...ence linking gastroesophageal reflux disease (GERD...y Medical Center researchers. , An association ...1970s, and since then studies have shown that betw...lso experience GERD symptoms. But the actual link ...
(Date:7/25/2008)...ou are an Olympian, Professional Athlete, Elite Am...u Need to Know about Hydration to Boost Sports Per...r , Marina del Rey, Calif...tes are heading to Beijing following years of inte...pes of capturing an Olympic medal and securing the...
(Date:7/24/2008)...ers at Wake Forest University Baptist Medical Cent...that the hepatitis C virus slows or stunts the imm...atients are treated with a combination of drugs kn...ction is more serious in HIV-infected people, lead...s for Disease Control. Intravenous drug use is a m...
Breaking Medicine News(10 mins):Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 3Health News:People With GERD More Likely to Develop Asthma 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 2Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 3Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 4Health News:Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know 5Health News:Researchers disprove long-standing belief about HIV treatment 2Health News:Researchers disprove long-standing belief about HIV treatment 3(Date:7/23/2008)... July 23 /- Dendreon Corpor...ects the Independent Data,Monitoring Committee (ID...,of overall survival relating to the Company,s Pha...noma Treatment, also known as D9902B) clinical tri...Company,s investigational,active cellular immunoth...
(Date:7/22/2008)...LIS, July 22 /- Nonin Medical, a lead...s for more than 20 years, has entered,the clinical... measure,regional oxygen saturation. Today,s most ...inuous monitoring of the regional blood oxygenatio...ng data and outcomes from an ongoing clinical stud...
(Date:7/22/2008)...the-Art PET Study Confirms Tyrima Exhibits Excelle...es - - Results Support Initiation of Phase I..., July 22 /- CeNeRx BioPharma,Inc., ...izing innovative,treatments for diseases of the ce...ance its lead candidate Tyrima(TM) into Phase II t...
(Date:7/22/2008)...ic treatment with chemotherapy and pegylated enzym...ared to chemotherapy alone - - Pe...22 /- Halozyme Therapeutics...ny developing and,commercializing products targeti...resentation of positive pre-clinical animal effica...
Breaking Medicine Technology:Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 2Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 3Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 4Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models 5Global Sound Conference Brings Worlds Top Sound Researchers Technologists and Musicians to Los Angeles for Four Day Symposium 14733 1Global Sound Conference Brings Worlds Top Sound Researchers Technologists and Musicians to Los Angeles for Four Day Symposium 14733 2Global Sound Conference Brings Worlds Top Sound Researchers Technologists and Musicians to Los Angeles for Four Day Symposium 14733 3FDA Identifies Contaminant in Blood Thinning Drug 14731 1FDA Identifies Contaminant in Blood Thinning Drug 14731 2FDA Identifies Contaminant in Blood Thinning Drug 14731 3PRA International Announces New Office Opening in Mumbai 14728 1PRA International Announces New Office Opening in Mumbai 14728 2Food insecurity linked with HIV AIDS in Africa 14725 1Food insecurity linked with HIV AIDS in Africa 14725 2...7 - Arrowhead,Research Corporation (NASDAQ:ARWR) a...ndo Pharmaceuticals has published,results in the P...AS) of the first non-human primate study to use mu...therapeutic candidate., Calando is using its propr... systems and siRNA design to create new, targeted,...
...2007 - Australian,biotechnology company Avexa (ASX...om its Phase IIb trial for apricitabine (ATC).,ATC... inhibitor,(NRTI) being developed for the treatmen... HIV., The Phase IIb trial compared the effectiven...with drug-resistant HIV with,the effectiveness of ...
Other Medicine Technology:Arrowhead Subsidiary, Calando Pharmaceuticals Publishes Study on,Targeted, Systemic Delivery of siRNA 2Arrowhead Subsidiary, Calando Pharmaceuticals Publishes Study on,Targeted, Systemic Delivery of siRNA 3Avexa Reports Positive Phase IIb Result 2Avexa Reports Positive Phase IIb Result 3Avexa Reports Positive Phase IIb Result 4